Table 1.
Prescriptions of dual-energy X-ray absorptiometry (DXA), supplements and osteoporosis medications, in cases with incident glucocorticoid therapy and in controls
| Overall population |
All males |
All females |
Females >55 years |
|||||
|---|---|---|---|---|---|---|---|---|
| Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | |
| DXA | 1175 (8.3)* | 421 (3) | 184 (3)* | 19 (0.3) | 991 (12.5)* | 402 (5.1) | 820 (18.7)* | 353 (8.1) |
| Calcium +vitamin D | 2542 (17.9)* | 559 (3.9) | 780 (12.4)* | 49 (0.8) | 1762 (22.3)* | 510 (6.5) | 1336 (30.5)* | 470 (10.7) |
| Bisphosphonates | 1729 (12.2)* | 355 (2.5) | 506 (8.0)* | 23 (0.4) | 1223 (15.5)* | 332 (4.2) | 1054 (24.1)* | 325 (7.4) |
| Any treatment | 5137 (36.2)* | 1646 (11.6) | 1660 (26.3)* | 258 (4.1) | 3477 (44)* | 1388 (17.6) | 2554 (58.4)* | 1195 (27.3) |
The data are n (%). *p<10−6.